One other comment Jeff that still no one can explain :)
Why did we have huge buying volume on 9/17-9/18 that drove the price up from $1.50 and topped out at $2.02 with a combined volume of 9.3 million shares?
It wasn't short covering. The short interest reported...
on 9/14 was 3.380 million shares, and
on 9/28 was 3.582 million shares
...now, could it possibly have been due to the Libigel 9th and final safety review that was communicated on 9/4??? It's obviously easy for us and for Simes to say that there was no positive market response to that news BUT what if manipulation by an interested 3rd party was the cause for the delayed response???
Sorry folks but these is still much that is unanswered here and Biosante is still way undervalued and the market response to this stock seems almost unreal to me which tells me that there is a big player controlling the price action until a planned trigger point, aimho.
Market Data 
Markets 
AI
